Search Within

Breast Medicine Service

Formats
  1. Journal Article (2206)
  2. Meeting Abstract (1680)
  3. Review (83)
  4. Book Section (69)
  5. Editorial (44)
  6. Conference Paper (28)
  7. Guidelines (27)
  8. Correspondence (16)
  9. Miscellaneous (12)
  10. Research Letter (11)
  11. Book Whole (5)
Groups
  1. Department of Medicine (4181)
  2. Solid Tumor Oncology Division (4181)
  3. Survivorship Research (2373)
  4. GSK Faculty (1516)
  5. Population Sciences Research Program (1369)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1144)

More Groups

People
  1. Clifford Hudis (906)
  2. Larry Norton (762)
  3. Mark Robson (684)
  4. Neal Rosen (427)
  5. Andrew Seidman (319)
  6. Kenneth Offit (300)

More People

Years
  1. 2025 (130)
  2. 2024 (195)
  3. 2023 (168)
  4. 2022 (219)
  5. 2021 (236)
  6. 2020 (250)

More Years

Publications
  1. Journal of Clinical Oncology (828)
  2. Cancer Research (481)
  3. Breast Cancer Research and Treatment (170)
  4. Annals of Oncology (159)
  5. Clinical Cancer Research (132)
  6. Cancer (78)

More Publications

Publishers
  1. American Society of Clinical Oncology (880)
  2. American Association for Cancer Research (755)
  3. Springer (332)
  4. Elsevier Inc. (308)
  5. Oxford University Press (282)
  6. Nature Publishing Group (276)

More Publishers

Results (4181)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • An estrogen receptor-negative breast cancer subset with over expression of hormone responsive genes
    Meeting Abstract

    Doane, A. S.; Danso, M. A.; Lal, P.; Donaton, M.; Zhang, L.; Hudis, C.; Gerald, W. L.
    Breast Cancer Research and Treatment (2005)

    Fulltext@MSK | Save
  • Prolonged dose-dense (DD) epirubicin and cyclophosphamide (EC) followed by paclitaxel (T) in breast cancer (BCA) is feasible
    Meeting Abstract

    Dang, C.; Smith, K.; Lake, D.; Fornier, M.; D'Andrea, G.; Seidman, A.; Sklarin, N.; Troso-Sandoval, T.; Sugarman, S.; Gilewski, T.; more...
    Breast Cancer Research and Treatment (2005)

    Fulltext@MSK | Save
  • Preliminary cardiac safety results of dose-dense (DD) doxorubicin and cyclophosphamide (AC) followed by paclitaxel (T) with trastuzumab (H) in HER2/neu overexpressed/amplified breast cancer (BCA)
    Meeting Abstract

    Dang, C.; Smith, K.; Lake, D.; Fornier, M.; D'Andrea, G.; Seidman, A.; Sklarin, N.; Troso-Sandoval, T.; Sugarman, S.; Gilewski, T.; more...
    Breast Cancer Research and Treatment (2005)

    Fulltext@MSK | Save
  • Dose-dense (DO) AC followed by paclitaxel is associated with moderate, frequent anemia compared to sequential (S) and/or less DD treatment: Update by CALGB on breast cancer intergroup trial C9741 with ECOG, SWOG, & NCCTG
    Meeting Abstract

    Citron, M. L.; Berry, D. A.; Cirrincione, C.; Livingston, R. B.; Gradishar, W.; Perez, E.; Muss, H.; Norton, L.; Winer, E.; Hudis, C.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Targeting wide-range oncogenic transformation via PU24FCl, a specific inhibitor of tumor Hsp90
    Meeting Abstract

    Chiosis, G.; Vilenchik, M.; Kim, J.; Aguirre, J.; Rosen, N.
    Annals of Oncology (2005)

    Fulltext@MSK | Save
  • Serum HER-2/neu has clinical utility in monitoring and prediction of progression-free survival in metastatic breast cancer patients treated with trastuzamab-based therapies
    Meeting Abstract

    Cheli, C. Q.; Esteva, F. J.; Fritsche, H.; Fornier, M.; Slamon, D.; Thiel, R. P.; Lueftner, D.; Ghani, F.
    Clinical Chemistry (2005)

    Fulltext@MSK | Save
  • SWOG/intergroup 9623: A phase III comparison of intensive sequential chemotherapy to high dose chemotherapy and autologous hematopoietic progenitor cell support (AHPCS) for primary breast cancer in women with >= 4 involved axillary lymph nodes
    Meeting Abstract

    Bearman, S. I.; Green, S.; Gralow, J.; Barlow, W.; Hudis, C.; Wolff, A.; Ingle, J.; Hortobagyi, G.; Livingston, R.; Martino, S.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Female sexual dysfunction and changes in hormonal levels in patients with early breast cancer on anti-estrogen therapy
    Meeting Abstract

    Amsterdam, A. D.; Wheler, J.; Hudis, C.; Krychman, M. L.
    Breast Cancer Research and Treatment (2005)

    Fulltext@MSK | Save
  • Effect of addition of adjuvant paclitaxel on radiotherapy delivery and locoregional control of node-positive breast cancer: Cancer and Leukemia Group B 9344
    Journal Article

    Sartor, C. L.; Peterson, B. L.; Woolf, S.; FitzGerald, T. J.; Laurie, F.; Turrisi, A. J.; Bogart, J.; Henderson, I. C.; Norton, L.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Prospective, randomized comparison of high-dose chemotherapy with stem-cell support versus intermediate-dose chemotherapy after surgery and adjuvant chemotherapy in women with high-risk primary breast cancer: A report of CALGB 9082, SWOG 9114, and NCIC MA-13
    Journal Article

    Peters, W. P.; Rosner, G. L.; Vredenburgh, J. J.; Shpall, E. J.; Crump, M.; Richardson, P. G.; Schuster, M. W.; Marks, L. B.; Cirrincione, C.; Norton, L.; more...
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save